Suchergebnisse - "Sebastian, Shaji"

PubPharm (192)

101

Practice pattern variability in the management of acute severe colitis : a UK provider survey

enthalten in: Frontline gastroenterology | 2020

von Sebastian, S. | Lisle, J. | Subramanian, S. | +12

102

Development and evaluation of a patient decision aid for patients considering ongoing medical or surgical treatment options for ulcerative colitis using a mixed-methods approach : protocol for DISCUSS study

enthalten in: BMJ open | 2020

von Baker, D. | Lee, M. | Folan, A. | +7

103

Organisational changes and challenges for inflammatory bowel disease services in the UK during the COVID-19 pandemic

enthalten in: Frontline gastroenterology | 2020

von Kennedy, N. | Hansen, R. | Younge, L. | +21

104

Letter : should we intensify infliximab in acute severe ulcerative colitis? Author's reply

enthalten in: Alimentary pharmacology & therapeutics | 2020

von Sebastian, S.

CommentOn: Aliment Pharmacol Ther. 2019 Sep;50(6):675-683. - PMID 31456297

105

Letter : should we intensify infliximab in acute severe ulcerative colitis? Author's reply

enthalten in: Alimentary Pharmacology & Therapeutics | 2020

von Sebastian, S.

106

Letter : infliximab induction regimens in steroid‐refractory acute severe colitis—a propensity score analysis. Authors' reply

enthalten in: Alimentary Pharmacology & Therapeutics | 2020

von Sebastian, S. | Myers, S.

107

Effectiveness of ustekinumab dose escalation in Crohn’s disease patients with insufficient response to standard‐dose subcutaneous maintenance therapy

enthalten in: Alimentary Pharmacology & Therapeutics | 2020

von Kopylov, U. | Hanzel, J. | Liefferinckx, C. | +33

108

The use of 5‐aminosalicylate for patients with Crohn’s disease in a prospective European inception cohort with 5 years follow‐up – an Epi‐IBD study

enthalten in: United European Gastroenterology Journal | 2020

von Burisch, J. | Bergemalm, D. | Halfvarson, J. | +44

109

Editorial : accelerated infliximab induction-it's time to settle the debate! Authors' reply

enthalten in: Alimentary pharmacology & therapeutics | 2019

von Sebastian, S. | Kennedy, N. | Subramanian, S. | +1

CommentOn: Aliment Pharmacol Ther. 2019 Sep;50(6):675-683. - PMID 31456297

110

IBD BioResource : an open-access platform of 25 000 patients to accelerate research in Crohn's and Colitis

enthalten in: Gut | 2019

von Parkes, M. | IBD BioResource Investigators | Abdelmalek, E. | +99